Team:NYMU-Taipei/FAQ
From 2009.igem.org
(Difference between revisions)
Blackrabbit (Talk | contribs)
(New page: Image:NYMU Wt--faq.png {{:Team:NYMU-Taipei/Header}} <html><style> .qa, .qr, .qan{ border: 1px solid gray; background: #eef; margin-left:10%; padding:5px; width:80%; } .qr{ margin-left...)
Newer edit →
(New page: Image:NYMU Wt--faq.png {{:Team:NYMU-Taipei/Header}} <html><style> .qa, .qr, .qan{ border: 1px solid gray; background: #eef; margin-left:10%; padding:5px; width:80%; } .qr{ margin-left...)
Newer edit →
Revision as of 19:47, 21 October 2009
Home | Project Overview: | Chassis | Receptors | Removal | Experiments and Parts | F.A.Q | About Us |
Contents |
General Questions
Add questions when you think of something. If you don't know the answer, leave it blank and someone else should be able to fill it in.
Q. What is this F.A.Q all about?
A. It's all about answering questions people might have.
Safe E. coli
Q. How can you sure your E. coli is really safe?
A. Reference to previous works from other iGEM teams, for example, the BactoBlood project of UC Berkeley, to see their strategies for making E. coli safe.
Cellular Receptors
Q. What are the binding affinities for each receptor?
A. Even our viro terminator can not bind the virus well, it can also build up the local concentration of virus, and then have the ability to attract microphage.
CD4 (HIV)
Q. What does the genome of HIV consist of?
A. The full HIV genome is encoded on one long strand of RNA. (In a free virus particle, there are actually two separate strands of RNA, but they're exactly the same!) This is the form it has when it is a free virus particle. When the virus is integrated into the host's DNA genome (as a provirus) then its information too is encoded in DNA. (from www.mcld.co.uk/hiv/)
Q. How dose the HIV enters a human cell?
A. HIV enter macrophage and CD4+ T cell of human cell by the adsorption of their glycoprtein on the traget receptor. Afetr adsorption finished, virus envelope fusion with membrane of target cell, then genome of HIV can entry the target cell.
Integrin (various viruses)
Sialic acid (Influenza)
Antibodies (Specific chosen viruses)
Host cell and signal transduction
Removal
in vivo questions
After clinical tests
Q. How can we control the number of E. coli in our blood?
A. We will make the E. coli not be able to replicate by ________
Q. What is the dosage required for say a person with flu?
A. This is a question for sometime between in vivo testing and clinical trials.